See more : Perception Capital Corp. II (PCCTU) Income Statement Analysis – Financial Results
Complete financial analysis of SofWave Medical Ltd. (SOFW.TA) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of SofWave Medical Ltd., a leading company in the Medical – Devices industry within the Healthcare sector.
- Fuji Nihon Seito Corporation (2114.T) Income Statement Analysis – Financial Results
- Suvo Strategic Minerals Limited (SUV.AX) Income Statement Analysis – Financial Results
- Nabaltec AG (NTG.DE) Income Statement Analysis – Financial Results
- Esaar (India) Limited (ESARIND.BO) Income Statement Analysis – Financial Results
- Shanxi Road & Bridge Co.,Ltd. (000755.SZ) Income Statement Analysis – Financial Results
SofWave Medical Ltd. (SOFW.TA)
About SofWave Medical Ltd.
Sofwave Medical Ltd. develops an ultrasound technology for treating fine lines and wrinkles in Israel and internationally. It offers non-invasive skin treatment aesthetic medical devices to physicians. The company was incorporated in 2015 and is based in Yokne'am Illit, Israel.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|
Revenue | 50.32M | 35.63M | 21.84M | 4.29M | 278.00K |
Cost of Revenue | 12.83M | 9.30M | 5.60M | 1.67M | 97.00K |
Gross Profit | 37.48M | 26.33M | 16.24M | 2.63M | 181.00K |
Gross Profit Ratio | 74.49% | 73.90% | 74.34% | 61.20% | 65.11% |
Research & Development | 11.43M | 12.44M | 8.24M | 4.59M | 2.63M |
General & Administrative | 1.70M | 2.52M | 1.86M | 811.00K | 322.00K |
Selling & Marketing | 12.42M | 8.56M | 3.83M | 1.40M | 181.00K |
SG&A | 14.12M | 11.08M | 5.69M | 2.21M | 503.00K |
Other Expenses | 19.92M | 0.00 | 0.00 | 0.00 | 0.00 |
Operating Expenses | 45.47M | 43.67M | 25.10M | 9.18M | 3.34M |
Cost & Expenses | 58.31M | 52.97M | 30.71M | 10.84M | 3.44M |
Interest Income | 713.00K | 330.00K | 31.00K | 14.00K | 23.00K |
Interest Expense | 144.00K | 1.12M | 549.00K | 333.00K | 231.00K |
Depreciation & Amortization | 1.51M | 1.12M | 359.00K | 65.00K | 17.00K |
EBITDA | -6.61M | -16.97M | -8.50M | -11.32M | -3.20M |
EBITDA Ratio | -13.14% | -47.63% | -38.90% | -153.46% | -1,185.97% |
Operating Income | -7.99M | -17.34M | -8.87M | -6.55M | -3.16M |
Operating Income Ratio | -15.88% | -48.66% | -40.60% | -152.67% | -1,137.41% |
Total Other Income/Expenses | -272.00K | -1.87M | 1.72M | -5.14M | -283.00K |
Income Before Tax | -8.26M | -19.21M | -7.15M | -11.69M | -3.45M |
Income Before Tax Ratio | -16.42% | -53.91% | -32.73% | -272.36% | -1,239.21% |
Income Tax Expense | 16.00K | 321.00K | -321.00K | -99.00K | -152.00K |
Net Income | -8.28M | -19.53M | -6.83M | -11.69M | -3.45M |
Net Income Ratio | -16.45% | -54.81% | -31.26% | -272.36% | -1,239.21% |
EPS | -0.24 | -0.57 | -0.29 | -0.35 | -0.10 |
EPS Diluted | -0.24 | -0.57 | -0.29 | -0.34 | -0.10 |
Weighted Avg Shares Out | 34.16M | 34.07M | 23.50M | 33.74M | 34.29M |
Weighted Avg Shares Out (Dil) | 34.16M | 34.07M | 23.50M | 34.29M | 34.29M |
Source: https://incomestatements.info
Category: Stock Reports